Corporate Governance

The Board of Directors is elected at a general meeting of the participants of the project. Of the Board’s seven members, three are appointed by Rusnano and four are selected from the candidates put forward by the other participants of the project.

At present the three representatives of Rusnano are: Andrei Malyshev (Chairman of the Board), Deputy CEO, Rusnano; Olga Shpichko, Managing Director for Investment in Medical Programs, Rusnano; and, Roman Knyazev, Senior Investment Manager, Rusnano.

Peter Krugliakov has been appointed as general director of the joint venture. He concurrently holds the position of Director of Research & Development at the Human Stem Cells Institute.